Joined Today: 1

PANC Panacos Pharmaceuticals, Stock Message Board

All Messages

PANC Message Board Home | Join The PANC Group |

#33: PANC Stock: Panacos Announces Results of Bevirimat Prospective Study, which Confirm Patient Response Predictors
NewsBot	June 19, 2008 06:27:15 PM
Completed Phase 2b Extension Study Determines Likely Phase 3 Patient Profile Panacos Pharmaceuticals, Inc. (NASDAQ: PANC) today announced the completion of a Phase 2b... view message ignore post recommend post

#32: Panacos Announces Results of Bevirimat 350 mg Cohort, Data Support Further Dose Escalation in Phase 2b Study
NewsBot	December 12, 2007 06:03:01 AM
Company to Hold a Conference Call at 5:00 p.m. EST Today Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of... view message ignore post recommend post

#31: Panacos to Report Third Quarter Results for 2007
FastFun	October 26, 2007 09:08:27 AM
Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, announced today that the Company will... view message ignore post recommend post

#30: Panacos Announces Management Changes
FastFun	October 26, 2007 09:07:58 AM
Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced the resignation of... view message ignore post recommend post

#29: PANC News Panacos Announces Bevirimat Phase 2b Dose Escalation Strategy
NewsBot	March 12, 2007 01:02:00 PM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

#28: PANC News Panacos to Present at Citigroup Small & Mid-Cap Conference
NewsBot	March 8, 2007 05:51:00 AM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

#27: PANC News Panacos to Present at Cowen Health Care Conference
NewsBot	March 6, 2007 05:35:00 AM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

#26: PANC News Panacos Begins Phase 1 Clinical Study of Second Generation Maturation Inhibitor PA-040
NewsBot	February 27, 2007 05:41:00 AM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

#25: PANC News Panacos Reports Fourth Quarter and Full Year 2006 Financial Results
NewsBot	February 21, 2007 01:02:00 PM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

#24: PANC News Panacos to Report Fourth Quarter and Year-End Results for 2006
NewsBot	February 14, 2007 01:00:00 PM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

#23: PANC News Panacos Appoints Dr. Tom Lategan, Vice President of Regulatory Affairs
NewsBot	February 14, 2007 05:00:00 AM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

#22: PANC News Panacos Appoints Alan W. Dunton, M.D. as New CEO
NewsBot	January 8, 2007 05:00:00 AM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

#21: PANC News Panacos to Present at 2007 JPMorgan Healthcare Conference
NewsBot	January 3, 2007 05:00:00 AM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

#20: PANC News Panacos Files IND for Second-Generation Maturation Inhibitor
NewsBot	December 21, 2006 01:02:00 PM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

#19: PANC News Panacos Announces First Cohort Results of Phase 2b Study
NewsBot	December 19, 2006 01:02:00 PM
WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (Nasdaq:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products,... view message ignore post recommend post

Group Home | Login if you want to post a message